 | • レポートコード：QYR2104Z1684 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、皮膚肥満細胞症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗ヒスタミン薬、コルチコステロイド、プロトンポンプ阻害薬、免疫調節薬、肥満細胞安定剤）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・皮膚肥満細胞症の市場動向 ・企業の競争状況、市場シェア ・皮膚肥満細胞症の種類別市場規模（抗ヒスタミン薬、コルチコステロイド、プロトンポンプ阻害薬、免疫調節薬、肥満細胞安定剤） ・皮膚肥満細胞症の用途別市場規模（病院、外来手術センター、その他） ・皮膚肥満細胞症の北米市場規模2016-2027（アメリカ、カナダ） ・皮膚肥満細胞症のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・皮膚肥満細胞症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・皮膚肥満細胞症の中南米市場規模2016-2027（メキシコ、ブラジル） ・皮膚肥満細胞症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AB Science、Novartis、BioCentury、Rarediseases） ・結論 |
Mastocytosis is rare condition characterized by excessive accumulation of mast cells in the body tissues. Mast cells release large amounts of histamine in blood which leads to itchy skin, skin rash and hot flushes. These cells are found in skin and the lining of stomach and lungs. Mast cells accumulated in the skin is referred to as cutaneous mastocytosis. Usually affecting children, the most common symptoms of cutaneous mastocytosis is abnormal growth on the skin such as spots or blisters which can form a rash on the body. The World Health Organization (WHO) has classified cutaneous mastocytosis into three variants namely urticaria pigmentosa, diffuse cutaneous mastocytosis and solitary cutaneous mastocytosis. Besides these, there are two other forms of cutaneous mastocytosis namely nodular mastocytosis and telangiectasia macularis eruptive perstans (TMEP) which are currently under review as they are very rare form of condition.
Treatment for cutaneous mastocytosis mainly aims to relieve symptoms. Therefore, medications such as antihistamines, corticosteroids, proton pump inhibitors, immunomodulators and mast cell stabilizers. Cromolyn sodium oral solution is the only FDA approved medication for the treatment of mastocytosis. However, these products are often associated with undesired side effects including hypo pigmentation, acne, skin thinning and secondary infection. With limited evidence to support their long term safety, there is a huge opportunity for novel and effective therapies.
Market Analysis and Insights: Global Cutaneous Mastocytosis Market
The global Cutaneous Mastocytosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cutaneous Mastocytosis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cutaneous Mastocytosis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cutaneous Mastocytosis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cutaneous Mastocytosis market.
Global Cutaneous Mastocytosis Scope and Market Size
Cutaneous Mastocytosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cutaneous Mastocytosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Antihistamines
Corticosteroids
Proton Pump Inhibitors
Immunomodulators
Mast Cell Stabilizers
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AB Science
Novartis
BioCentury
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cutaneous Mastocytosis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antihistamines
1.2.3 Corticosteroids
1.2.4 Proton Pump Inhibitors
1.2.5 Immunomodulators
1.2.6 Mast Cell Stabilizers
1.3 Market by Application
1.3.1 Global Cutaneous Mastocytosis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cutaneous Mastocytosis Market Perspective (2016-2027)
2.2 Cutaneous Mastocytosis Growth Trends by Regions
2.2.1 Cutaneous Mastocytosis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cutaneous Mastocytosis Historic Market Share by Regions (2016-2021)
2.2.3 Cutaneous Mastocytosis Forecasted Market Size by Regions (2022-2027)
2.3 Cutaneous Mastocytosis Industry Dynamic
2.3.1 Cutaneous Mastocytosis Market Trends
2.3.2 Cutaneous Mastocytosis Market Drivers
2.3.3 Cutaneous Mastocytosis Market Challenges
2.3.4 Cutaneous Mastocytosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cutaneous Mastocytosis Players by Revenue
3.1.1 Global Top Cutaneous Mastocytosis Players by Revenue (2016-2021)
3.1.2 Global Cutaneous Mastocytosis Revenue Market Share by Players (2016-2021)
3.2 Global Cutaneous Mastocytosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cutaneous Mastocytosis Revenue
3.4 Global Cutaneous Mastocytosis Market Concentration Ratio
3.4.1 Global Cutaneous Mastocytosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cutaneous Mastocytosis Revenue in 2020
3.5 Cutaneous Mastocytosis Key Players Head office and Area Served
3.6 Key Players Cutaneous Mastocytosis Product Solution and Service
3.7 Date of Enter into Cutaneous Mastocytosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cutaneous Mastocytosis Breakdown Data by Type
4.1 Global Cutaneous Mastocytosis Historic Market Size by Type (2016-2021)
4.2 Global Cutaneous Mastocytosis Forecasted Market Size by Type (2022-2027)
5 Cutaneous Mastocytosis Breakdown Data by Application
5.1 Global Cutaneous Mastocytosis Historic Market Size by Application (2016-2021)
5.2 Global Cutaneous Mastocytosis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cutaneous Mastocytosis Market Size (2016-2027)
6.2 North America Cutaneous Mastocytosis Market Size by Type
6.2.1 North America Cutaneous Mastocytosis Market Size by Type (2016-2021)
6.2.2 North America Cutaneous Mastocytosis Market Size by Type (2022-2027)
6.2.3 North America Cutaneous Mastocytosis Market Size by Type (2016-2027)
6.3 North America Cutaneous Mastocytosis Market Size by Application
6.3.1 North America Cutaneous Mastocytosis Market Size by Application (2016-2021)
6.3.2 North America Cutaneous Mastocytosis Market Size by Application (2022-2027)
6.3.3 North America Cutaneous Mastocytosis Market Size by Application (2016-2027)
6.4 North America Cutaneous Mastocytosis Market Size by Country
6.4.1 North America Cutaneous Mastocytosis Market Size by Country (2016-2021)
6.4.2 North America Cutaneous Mastocytosis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cutaneous Mastocytosis Market Size (2016-2027)
7.2 Europe Cutaneous Mastocytosis Market Size by Type
7.2.1 Europe Cutaneous Mastocytosis Market Size by Type (2016-2021)
7.2.2 Europe Cutaneous Mastocytosis Market Size by Type (2022-2027)
7.2.3 Europe Cutaneous Mastocytosis Market Size by Type (2016-2027)
7.3 Europe Cutaneous Mastocytosis Market Size by Application
7.3.1 Europe Cutaneous Mastocytosis Market Size by Application (2016-2021)
7.3.2 Europe Cutaneous Mastocytosis Market Size by Application (2022-2027)
7.3.3 Europe Cutaneous Mastocytosis Market Size by Application (2016-2027)
7.4 Europe Cutaneous Mastocytosis Market Size by Country
7.4.1 Europe Cutaneous Mastocytosis Market Size by Country (2016-2021)
7.4.2 Europe Cutaneous Mastocytosis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cutaneous Mastocytosis Market Size (2016-2027)
8.2 Asia-Pacific Cutaneous Mastocytosis Market Size by Type
8.2.1 Asia-Pacific Cutaneous Mastocytosis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cutaneous Mastocytosis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cutaneous Mastocytosis Market Size by Type (2016-2027)
8.3 Asia-Pacific Cutaneous Mastocytosis Market Size by Application
8.3.1 Asia-Pacific Cutaneous Mastocytosis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cutaneous Mastocytosis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cutaneous Mastocytosis Market Size by Application (2016-2027)
8.4 Asia-Pacific Cutaneous Mastocytosis Market Size by Region
8.4.1 Asia-Pacific Cutaneous Mastocytosis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cutaneous Mastocytosis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cutaneous Mastocytosis Market Size (2016-2027)
9.2 Latin America Cutaneous Mastocytosis Market Size by Type
9.2.1 Latin America Cutaneous Mastocytosis Market Size by Type (2016-2021)
9.2.2 Latin America Cutaneous Mastocytosis Market Size by Type (2022-2027)
9.2.3 Latin America Cutaneous Mastocytosis Market Size by Type (2016-2027)
9.3 Latin America Cutaneous Mastocytosis Market Size by Application
9.3.1 Latin America Cutaneous Mastocytosis Market Size by Application (2016-2021)
9.3.2 Latin America Cutaneous Mastocytosis Market Size by Application (2022-2027)
9.3.3 Latin America Cutaneous Mastocytosis Market Size by Application (2016-2027)
9.4 Latin America Cutaneous Mastocytosis Market Size by Country
9.4.1 Latin America Cutaneous Mastocytosis Market Size by Country (2016-2021)
9.4.2 Latin America Cutaneous Mastocytosis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cutaneous Mastocytosis Market Size (2016-2027)
10.2 Middle East & Africa Cutaneous Mastocytosis Market Size by Type
10.2.1 Middle East & Africa Cutaneous Mastocytosis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cutaneous Mastocytosis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cutaneous Mastocytosis Market Size by Type (2016-2027)
10.3 Middle East & Africa Cutaneous Mastocytosis Market Size by Application
10.3.1 Middle East & Africa Cutaneous Mastocytosis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cutaneous Mastocytosis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cutaneous Mastocytosis Market Size by Application (2016-2027)
10.4 Middle East & Africa Cutaneous Mastocytosis Market Size by Country
10.4.1 Middle East & Africa Cutaneous Mastocytosis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cutaneous Mastocytosis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AB Science
11.1.1 AB Science Company Details
11.1.2 AB Science Business Overview
11.1.3 AB Science Cutaneous Mastocytosis Introduction
11.1.4 AB Science Revenue in Cutaneous Mastocytosis Business (2016-2021)
11.1.5 AB Science Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Cutaneous Mastocytosis Introduction
11.2.4 Novartis Revenue in Cutaneous Mastocytosis Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 BioCentury
11.3.1 BioCentury Company Details
11.3.2 BioCentury Business Overview
11.3.3 BioCentury Cutaneous Mastocytosis Introduction
11.3.4 BioCentury Revenue in Cutaneous Mastocytosis Business (2016-2021)
11.3.5 BioCentury Recent Development
11.4 Rarediseases
11.4.1 Rarediseases Company Details
11.4.2 Rarediseases Business Overview
11.4.3 Rarediseases Cutaneous Mastocytosis Introduction
11.4.4 Rarediseases Revenue in Cutaneous Mastocytosis Business (2016-2021)
11.4.5 Rarediseases Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cutaneous Mastocytosis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antihistamines
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Proton Pump Inhibitors
Table 5. Key Players of Immunomodulators
Table 6. Key Players of Mast Cell Stabilizers
Table 7. Global Cutaneous Mastocytosis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cutaneous Mastocytosis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Cutaneous Mastocytosis Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Cutaneous Mastocytosis Market Share by Regions (2016-2021)
Table 11. Global Cutaneous Mastocytosis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Cutaneous Mastocytosis Market Share by Regions (2022-2027)
Table 13. Cutaneous Mastocytosis Market Trends
Table 14. Cutaneous Mastocytosis Market Drivers
Table 15. Cutaneous Mastocytosis Market Challenges
Table 16. Cutaneous Mastocytosis Market Restraints
Table 17. Global Cutaneous Mastocytosis Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Cutaneous Mastocytosis Market Share by Players (2016-2021)
Table 19. Global Top Cutaneous Mastocytosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cutaneous Mastocytosis as of 2020)
Table 20. Ranking of Global Top Cutaneous Mastocytosis Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Cutaneous Mastocytosis Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cutaneous Mastocytosis Product Solution and Service
Table 24. Date of Enter into Cutaneous Mastocytosis Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cutaneous Mastocytosis Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Cutaneous Mastocytosis Revenue Market Share by Type (2016-2021)
Table 28. Global Cutaneous Mastocytosis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Cutaneous Mastocytosis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Cutaneous Mastocytosis Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Cutaneous Mastocytosis Revenue Market Share by Application (2016-2021)
Table 32. Global Cutaneous Mastocytosis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Cutaneous Mastocytosis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Cutaneous Mastocytosis Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Cutaneous Mastocytosis Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Cutaneous Mastocytosis Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Cutaneous Mastocytosis Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Cutaneous Mastocytosis Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Cutaneous Mastocytosis Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Cutaneous Mastocytosis Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Cutaneous Mastocytosis Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Cutaneous Mastocytosis Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Cutaneous Mastocytosis Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Cutaneous Mastocytosis Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Cutaneous Mastocytosis Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cutaneous Mastocytosis Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cutaneous Mastocytosis Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cutaneous Mastocytosis Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Cutaneous Mastocytosis Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Cutaneous Mastocytosis Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Cutaneous Mastocytosis Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Cutaneous Mastocytosis Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Cutaneous Mastocytosis Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Cutaneous Mastocytosis Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Cutaneous Mastocytosis Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Cutaneous Mastocytosis Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Cutaneous Mastocytosis Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cutaneous Mastocytosis Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cutaneous Mastocytosis Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cutaneous Mastocytosis Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Cutaneous Mastocytosis Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Cutaneous Mastocytosis Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Cutaneous Mastocytosis Market Size by Country (2022-2027) & (US$ Million)
Table 64. AB Science Company Details
Table 65. AB Science Business Overview
Table 66. AB Science Cutaneous Mastocytosis Product
Table 67. AB Science Revenue in Cutaneous Mastocytosis Business (2016-2021) & (US$ Million)
Table 68. AB Science Recent Development
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis Cutaneous Mastocytosis Product
Table 72. Novartis Revenue in Cutaneous Mastocytosis Business (2016-2021) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. BioCentury Company Details
Table 75. BioCentury Business Overview
Table 76. BioCentury Cutaneous Mastocytosis Product
Table 77. BioCentury Revenue in Cutaneous Mastocytosis Business (2016-2021) & (US$ Million)
Table 78. BioCentury Recent Development
Table 79. Rarediseases Company Details
Table 80. Rarediseases Business Overview
Table 81. Rarediseases Cutaneous Mastocytosis Product
Table 82. Rarediseases Revenue in Cutaneous Mastocytosis Business (2016-2021) & (US$ Million)
Table 83. Rarediseases Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cutaneous Mastocytosis Market Share by Type: 2020 VS 2027
Figure 2. Antihistamines Features
Figure 3. Corticosteroids Features
Figure 4. Proton Pump Inhibitors Features
Figure 5. Immunomodulators Features
Figure 6. Mast Cell Stabilizers Features
Figure 7. Global Cutaneous Mastocytosis Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Cutaneous Mastocytosis Report Years Considered
Figure 12. Global Cutaneous Mastocytosis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Cutaneous Mastocytosis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Cutaneous Mastocytosis Market Share by Regions: 2020 VS 2027
Figure 15. Global Cutaneous Mastocytosis Market Share by Regions (2022-2027)
Figure 16. Global Cutaneous Mastocytosis Market Share by Players in 2020
Figure 17. Global Top Cutaneous Mastocytosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cutaneous Mastocytosis as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Cutaneous Mastocytosis Revenue in 2020
Figure 19. Global Cutaneous Mastocytosis Revenue Market Share by Type (2016-2021)
Figure 20. Global Cutaneous Mastocytosis Revenue Market Share by Type (2022-2027)
Figure 21. North America Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Cutaneous Mastocytosis Market Share by Type (2016-2027)
Figure 23. North America Cutaneous Mastocytosis Market Share by Application (2016-2027)
Figure 24. North America Cutaneous Mastocytosis Market Share by Country (2016-2027)
Figure 25. United States Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Cutaneous Mastocytosis Market Share by Type (2016-2027)
Figure 29. Europe Cutaneous Mastocytosis Market Share by Application (2016-2027)
Figure 30. Europe Cutaneous Mastocytosis Market Share by Country (2016-2027)
Figure 31. Germany Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Cutaneous Mastocytosis Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Cutaneous Mastocytosis Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Cutaneous Mastocytosis Market Share by Region (2016-2027)
Figure 41. China Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Cutaneous Mastocytosis Market Share by Type (2016-2027)
Figure 49. Latin America Cutaneous Mastocytosis Market Share by Application (2016-2027)
Figure 50. Latin America Cutaneous Mastocytosis Market Share by Country (2016-2027)
Figure 51. Mexico Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Cutaneous Mastocytosis Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Cutaneous Mastocytosis Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Cutaneous Mastocytosis Market Share by Country (2016-2027)
Figure 57. Turkey Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Cutaneous Mastocytosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. AB Science Revenue Growth Rate in Cutaneous Mastocytosis Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Cutaneous Mastocytosis Business (2016-2021)
Figure 62. BioCentury Revenue Growth Rate in Cutaneous Mastocytosis Business (2016-2021)
Figure 63. Rarediseases Revenue Growth Rate in Cutaneous Mastocytosis Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
世界の外来手術センター市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Ambulatory Surgical Centres Market The global Ambulatory Surgical Centres market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…- 世界の陽子線治療センター市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Proton Room Market The global Proton Room market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant a…
- 世界の病院・外来診療センター市場規模・現状・予測（2021年-2027年） Hospitals and outpatient centers are medical facilities that provide diagnostic and medical treatment to patients with a wide range of medical conditions. Outpatient care centers offer medical care or treatment that does not require any overnight stay in a hospital or medical facility. Outpatient ca…
- 世界の鎌状赤血球市場規模・現状・予測（2021年-2027年） The global sickle cell market is expected to grow in future due to rising African-American population, economic growth, increasing healthcare expenditure and prevalence of sickle cell. Key trends of this market include progressing drug pipeline and rising research grants. However, there are some fac…
- 世界のMRI-互換性IV輸液ポンプシステム市場規模・現状・予測（2021年-2027年） Healthcare providers across the globe are increasingly aware of occupational risks arising due to the use of magnetic MRI-compatible IV infusion pump systems. Magnetic MRI-compatible IV infusion pump systems may create safety concerns and could be harmful to patients as well as MRI operators. The ma…